CompletedPhase 3

A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes

NCT01849289

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novo Nordisk Investigational Site

Anaheim, California, United States

+80 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2013-06-02
Enrollment: 833 participants
Sponsor: Novo Nordisk A/S
Purpose: treatment

Locations (81)

Novo Nordisk Investigational SiteAnaheim, California, United States
Novo Nordisk Investigational SiteLomita, California, United States
Novo Nordisk Investigational SiteLos Angeles, California, United States
Novo Nordisk Investigational SiteGolden, Colorado, United States
Novo Nordisk Investigational SiteClearwater, Florida, United States
Novo Nordisk Investigational SiteChicago, Illinois, United States
Novo Nordisk Investigational SiteCrestview Hills, Kentucky, United States
Novo Nordisk Investigational SiteMetairie, Louisiana, United States
Novo Nordisk Investigational SiteTroy, Michigan, United States
Novo Nordisk Investigational SiteChesterfield, Missouri, United States
Novo Nordisk Investigational SiteNashua, New Hampshire, United States
Novo Nordisk Investigational SiteToms River, New Jersey, United States
Novo Nordisk Investigational SiteSmithtown, New York, United States
Novo Nordisk Investigational SiteSimpsonville, South Carolina, United States
Novo Nordisk Investigational SiteJackson, Tennessee, United States
Novo Nordisk Investigational SiteDallas, Texas, United States
Novo Nordisk Investigational SiteNewport News, Virginia, United States
Novo Nordisk Investigational SiteKenosha, Wisconsin, United States
Novo Nordisk Investigational SiteSão Paulo, São Paulo, Brazil
Novo Nordisk Investigational SitePorto Alegre, Brazil
Novo Nordisk Investigational SiteSão Paulo, Brazil
Novo Nordisk Investigational SiteCalgary, Alberta, Canada
Novo Nordisk Investigational SiteBurnaby, British Columbia, Canada
Novo Nordisk Investigational SiteSurrey, British Columbia, Canada
Novo Nordisk Investigational SiteVictoria, British Columbia, Canada
Novo Nordisk Investigational SiteBurlington, Ontario, Canada
Novo Nordisk Investigational SiteLondon, Ontario, Canada
Novo Nordisk Investigational SiteLondon, Ontario, Canada
Novo Nordisk Investigational SiteNewmarket, Ontario, Canada
Novo Nordisk Investigational SiteSarnia, Ontario, Canada
Novo Nordisk Investigational SiteStrathroy, Ontario, Canada
Novo Nordisk Investigational SiteQuébec, Quebec, Canada
Novo Nordisk Investigational SiteTrois-Rivières, Quebec, Canada
Novo Nordisk Investigational SiteHefei, Anhui, China
Novo Nordisk Investigational SiteBeijing, Beijing Municipality, China
Novo Nordisk Investigational SiteBeijing, Beijing Municipality, China
Novo Nordisk Investigational SiteBeijing, Beijing Municipality, China
Novo Nordisk Investigational SiteBeijing, Beijing Municipality, China
Novo Nordisk Investigational SiteBeijing, Beijing Municipality, China
Novo Nordisk Investigational SiteBeijing, Beijing Municipality, China
Novo Nordisk Investigational SiteChongqing, Chongqing Municipality, China
Novo Nordisk Investigational SiteChongqing, Chongqing Municipality, China
Novo Nordisk Investigational SiteChongqing, Chongqing Municipality, China
Novo Nordisk Investigational SiteFuzhou, Fujian, China
Novo Nordisk Investigational SiteGuangzhou, Guangdong, China
Novo Nordisk Investigational SiteNanning, Guangxi, China
Novo Nordisk Investigational SiteGuiyang, Guizhou, China
Novo Nordisk Investigational SiteShijiazhuang, Hebei, China
Novo Nordisk Investigational SiteShijiazhuang, Hebei, China
Novo Nordisk Investigational SiteHarbin, Heilongjiang, China
Novo Nordisk Investigational SiteWuhan, Hubei, China
Novo Nordisk Investigational SiteWuhan, Hubei, China
Novo Nordisk Investigational SiteYueyang, Hunan, China
Novo Nordisk Investigational SiteYangzhou, Jiangsu, China
Novo Nordisk Investigational SiteZhenjiang, Jiangsu, China
Novo Nordisk Investigational SiteNanchang, Jiangxi, China
Novo Nordisk Investigational SiteChangchun, Jilin, China
Novo Nordisk Investigational SiteSiping, Jilin, China
Novo Nordisk Investigational SiteShenyang, Liaoning, China
Novo Nordisk Investigational SiteShenyang, Liaoning, China
Novo Nordisk Investigational SiteXi'an, Shaanxi, China
Novo Nordisk Investigational SiteShanghai, Shanghai Municipality, China
Novo Nordisk Investigational SiteShanghai, Shanghai Municipality, China
Novo Nordisk Investigational SiteKunming, Yunnan, China
Novo Nordisk Investigational SiteHangzhou, Zhejiang, China
Novo Nordisk Investigational SiteWenzhou, Zhejiang, China
Novo Nordisk Investigational SiteOradea, Bihor County, Romania
Novo Nordisk Investigational SiteBuzău, Buzău, Romania
Novo Nordisk Investigational SiteSibiu, Sibiu County, Romania
Novo Nordisk Investigational SiteBucharest, Romania
Novo Nordisk Investigational SiteGalati, Romania
Novo Nordisk Investigational SiteGeorge, Eastern Cape, South Africa
Novo Nordisk Investigational SiteJohannesburg, Gauteng, South Africa
Novo Nordisk Investigational SiteJohannesburg, Gauteng, South Africa
Novo Nordisk Investigational SiteDurban, KwaZulu-Natal, South Africa
Novo Nordisk Investigational SiteDurban, KwaZulu-Natal, South Africa
Novo Nordisk Investigational SiteDnipro, Ukraine
Novo Nordisk Investigational SiteDnipro, Ukraine
Novo Nordisk Investigational SiteKiev, Ukraine
Novo Nordisk Investigational SiteMykolaiv, Ukraine
Novo Nordisk Investigational SiteVinnitsa, Ukraine